SRTS vs. SEPA, AMIX, PDEX, MGRM, ICCM, NVNO, APYX, HSAQ, DXR, and NSPR
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include SEP Acquisition (SEPA), Autonomix Medical (AMIX), Pro-Dex (PDEX), Monogram Orthopaedics (MGRM), IceCure Medical (ICCM), enVVeno Medical (NVNO), Apyx Medical (APYX), Health Sciences Acquisitions Co. 2 (HSAQ), Daxor (DXR), and InspireMD (NSPR). These companies are all part of the "surgical & medical instruments" industry.
Sensus Healthcare (NASDAQ:SRTS) and SEP Acquisition (NASDAQ:SEPA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership.
Sensus Healthcare received 176 more outperform votes than SEP Acquisition when rated by MarketBeat users.
Sensus Healthcare has higher revenue and earnings than SEP Acquisition.
Sensus Healthcare has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, SEP Acquisition has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.
Sensus Healthcare presently has a consensus price target of $8.00, indicating a potential upside of 119.18%. Given Sensus Healthcare's higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than SEP Acquisition.
Sensus Healthcare has a net margin of 1.99% compared to SEP Acquisition's net margin of 0.00%. Sensus Healthcare's return on equity of 1.04% beat SEP Acquisition's return on equity.
25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 3.7% of SEP Acquisition shares are owned by institutional investors. 11.1% of Sensus Healthcare shares are owned by company insiders. Comparatively, 20.0% of SEP Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Sensus Healthcare had 1 more articles in the media than SEP Acquisition. MarketBeat recorded 2 mentions for Sensus Healthcare and 1 mentions for SEP Acquisition. SEP Acquisition's average media sentiment score of 1.95 beat Sensus Healthcare's score of 0.53 indicating that SEP Acquisition is being referred to more favorably in the news media.
Summary
Sensus Healthcare beats SEP Acquisition on 11 of the 13 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
